Scope and consequences of peptic ulcer disease -: How important is asymptomatic Helicobacter pylori infection?

被引:15
作者
Graham, DY
Rakel, RE
Fendrick, AM
Go, MF
Marshall, BJ
Peura, DA
Scherger, JE
机构
[1] Vet Affairs Med Ctr, Gastroenterol Sect, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Div Digest Dis, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA
[4] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
[5] Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA
[6] Univ Virginia, Sch Med, Independent Res Facil, Charlottesville, VA 22908 USA
[7] Univ Virginia, Sch Med, Div Gastroenterol & Hepatol, Charlottesville, VA 22903 USA
[8] Univ Virginia, Sch Med, Helicobacter Pylori Res Lab, Charlottesville, VA 22903 USA
[9] Univ Calif Irvine, Coll Med, Dept Family Med, Irvine, CA 92717 USA
关键词
D O I
10.3810/pgm.1999.03.593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
H-pylori infection is so common as to seem ubiquitous in many areas of the world. Transmission is believed to be primarily person to person. The pathogen invariably damages the gastric mucosa, resulting in both structural and functional abnormalities. It causes histologic gastritis and is critical in the pathogenesis of the gastritis-associated diseases, namely, gastric ulcer, duodenal ulcer, gastric adenocarcinoma, and primary gastric lymphoma. Elimination of the infection results in healing of gastritis and cure of peptic ulcer disease.
引用
收藏
页码:100 / +
页数:8
相关论文
共 36 条
  • [1] [Anonymous], LANCET
  • [2] Gastric MALT-lymphoma and Helicobacter pylori infection
    Bayerdorffer, E
    Miehlke, S
    Neubauer, A
    Stolte, M
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 : 89 - 94
  • [3] Not all Helicobacter pylori strains are created equal: Should all be eliminated?
    Blaser, MJ
    [J]. LANCET, 1997, 349 (9057) : 1020 - 1022
  • [4] Carlson SJ, 1996, JAMA-J AM MED ASSOC, V275, P937
  • [5] MOLECULAR CHARACTERIZATION OF THE 128-KDA IMMUNODOMINANT ANTIGEN OF HELICOBACTER-PYLORI-ASSOCIATED WITH CYTOTOXICITY AND DUODENAL-ULCER
    COVACCI, A
    CENSINI, S
    BUGNOLI, M
    PETRACCA, R
    BURRONI, D
    MACCHIA, G
    MASSONE, A
    PAPINI, E
    XIANG, ZY
    FIGURA, N
    RAPPUOLI, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5791 - 5795
  • [6] CORRELATION BETWEEN VACUOLATING CYTOTOXIN PRODUCTION BY HELICOBACTER-PYLORI ISOLATES IN-VITRO AND IN-VIVO
    COVER, TL
    CAO, P
    LIND, CD
    THAM, KT
    BLASER, MJ
    [J]. INFECTION AND IMMUNITY, 1993, 61 (12) : 5008 - 5012
  • [7] CHARACTERIZATION OF AND HUMAN SEROLOGIC RESPONSE TO PROTEINS IN HELICOBACTER-PYLORI BROTH CULTURE SUPERNATANTS WITH VACUOLIZING CYTOTOXIN ACTIVITY
    COVER, TL
    DOOLEY, CP
    BLASER, MJ
    [J]. INFECTION AND IMMUNITY, 1990, 58 (03) : 603 - 610
  • [8] SYSTEMIC AND MUCOSAL HUMORAL RESPONSES TO HELICOBACTER-PYLORI IN GASTRIC-CANCER
    CRABTREE, JE
    WYATT, JI
    SOBALA, GM
    MILLER, G
    TOMPKINS, DS
    PRIMROSE, JN
    MORGAN, AG
    [J]. GUT, 1993, 34 (10) : 1339 - 1343
  • [9] MUCOSAL IGA RECOGNITION OF HELICOBACTER-PYLORI 120-KDA PROTEIN, PEPTIC-ULCERATION, AND GASTRIC PATHOLOGY
    CRABTREE, JE
    TAYLOR, JD
    WYATT, JI
    HEATLEY, RV
    SHALLCROSS, TM
    TOMPKINS, DS
    RATHBONE, BJ
    [J]. LANCET, 1991, 338 (8763) : 332 - 335
  • [10] FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672